142 related articles for article (PubMed ID: 2039696)
1. Bioactivity of skeletal muscle proteolysis-inducing factors in the plasma proteins from cancer patients with weight loss.
Belizario JE; Katz M; Chenker E; Raw I
Br J Cancer; 1991 May; 63(5):705-10. PubMed ID: 2039696
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor induces skeletal muscle protein breakdown in rats.
Goodman MN
Am J Physiol; 1991 May; 260(5 Pt 1):E727-30. PubMed ID: 2035628
[TBL] [Abstract][Full Text] [Related]
3. Effect of plasma from cancer patients on rat skeletal muscle protein degradation and PGE2 release in vitro.
Civelli M; Agradi E; Bozzetti F; Letari O; Nicosia S
Pharmacol Res; 1990; 22(2):87-95. PubMed ID: 2330345
[TBL] [Abstract][Full Text] [Related]
4. Effect of cancer plasma on skeletal muscle metabolism.
Mitchell LA; Norton LW
J Surg Res; 1989 Nov; 47(5):423-6. PubMed ID: 2682006
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of muscle protein degradation induced by a cancer cachectic factor.
Lorite MJ; Thompson MG; Drake JL; Carling G; Tisdale MJ
Br J Cancer; 1998 Oct; 78(7):850-6. PubMed ID: 9764574
[TBL] [Abstract][Full Text] [Related]
6. Is there a circulating proteolysis-inducing factor during sepsis?
Hasselgren PO; James JH; Benson DW; Li S; Fischer JE
Arch Surg; 1990 Apr; 125(4):510-4. PubMed ID: 2322118
[TBL] [Abstract][Full Text] [Related]
7. Activation of protein breakdown and prostaglandin E2 production in rat skeletal muscle in fever is signaled by a macrophage product distinct from interleukin 1 or other known monokines.
Goldberg AL; Kettelhut IC; Furuno K; Fagan JM; Baracos V
J Clin Invest; 1988 May; 81(5):1378-83. PubMed ID: 3284911
[TBL] [Abstract][Full Text] [Related]
8. Effects of tumor necrosis factor-alpha on muscle-protein turnover in female Wistar rats.
Llovera M; López-Soriano FJ; Argilés JM
J Natl Cancer Inst; 1993 Aug; 85(16):1334-9. PubMed ID: 8340946
[TBL] [Abstract][Full Text] [Related]
9. Further evidence that accelerated muscle protein breakdown during sepsis is not mediated by prostaglandin E2.
Hasselgren PO; Warner BW; Hummel RP; James JH; Ogle CK; Fischer JE
Ann Surg; 1988 Apr; 207(4):399-403. PubMed ID: 3162671
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 does not regulate total or myofibrillar protein breakdown in incubated skeletal muscle from normal or septic rats.
Hasselgren PO; Zamir O; James JH; Fischer JE
Biochem J; 1990 Aug; 270(1):45-50. PubMed ID: 2118760
[TBL] [Abstract][Full Text] [Related]
11. The 'cancer cachectic factor'.
Tisdale MJ
Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
[TBL] [Abstract][Full Text] [Related]
12. Cleavage of human interleukin 1: isolation of a peptide fragment from plasma of febrile humans and activated monocytes.
Dinarello CA; Clowes GH; Gordon AH; Saravis CA; Wolff SM
J Immunol; 1984 Sep; 133(3):1332-8. PubMed ID: 6611371
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of muscle protein degradation in cancer cachexia.
Smith KL; Tisdale MJ
Br J Cancer; 1993 Aug; 68(2):314-8. PubMed ID: 8347486
[TBL] [Abstract][Full Text] [Related]
14. Effect of indomethacin on proteolysis in septic muscle.
Hasselgren PO; Talamini M; LaFrance R; James JH; Peters JC; Fischer JE
Ann Surg; 1985 Nov; 202(5):557-62. PubMed ID: 3901942
[TBL] [Abstract][Full Text] [Related]
15. [Cytokines in experimental cancer cachexia].
Niu Q; Li T; Liu A
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):382-4. PubMed ID: 11810767
[TBL] [Abstract][Full Text] [Related]
16. Effect of a fluorinated pyrimidine on cachexia and tumour growth in murine cachexia models: relationship with a proteolysis inducing factor.
Hussey HJ; Todorov PT; Field WN; Inagaki N; Tanaka Y; Ishitsuka H; Tisdale MJ
Br J Cancer; 2000 Jul; 83(1):56-62. PubMed ID: 10883668
[TBL] [Abstract][Full Text] [Related]
17. Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia.
Smith KL; Tisdale MJ
Br J Cancer; 1993 Apr; 67(4):680-5. PubMed ID: 8471425
[TBL] [Abstract][Full Text] [Related]
18. Proteolysis-inducing factor regulates hepatic gene expression via the transcription factors NF-(kappa)B and STAT3.
Watchorn TM; Waddell I; Dowidar N; Ross JA
FASEB J; 2001 Mar; 15(3):562-4. PubMed ID: 11259367
[TBL] [Abstract][Full Text] [Related]
19. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
[TBL] [Abstract][Full Text] [Related]
20. Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour.
Mahony SM; Beck SA; Tisdale MJ
Br J Cancer; 1988 Apr; 57(4):385-9. PubMed ID: 3390373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
